Efficacy and safety of neoadjuvant therapy for HR-positive/HER2-negative early breast cancer: a Bayesian network meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of neoadjuvant therapy for HR-positive/HER2-negative early breast cancer: a Bayesian network meta-analysis

Published:2024-05-17 Issue:7 Volume:24 Page:599-611
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Chen Ruiliang¹²³^ORCID,Yu Yushuai³⁴,Zhang Jie¹²³,Song Chuangui³⁴,Wang Chuan¹²³

Affiliation:

1. Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China

2. Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China

3. Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian Province, China

4. Department of Breast Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2024.2350105

Reference67 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer

3. Treatment optimization in early triple negative breast cancer

4. New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer

5. Current and future role of neoadjuvant therapy for breast cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylation modification of non-histone proteins in breast cancer: An emerging targeted therapeutic strategy;Pharmacological Research;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3